مصطلحات الفهرس: diabetic nephropathy/di [Diagnosis], diabetic nephropathy/dt [Drug Therapy], diabetic nephropathy/ep [Epidemiology], diabetic nephropathy/et [Etiology], diabetic nephropathy/su [Surgery], diabetic nephropathy/th [Therapy], diet therapy, disease surveillance, drug effect, drug targeting, glycemic control, human, inflammation, intracellular signaling, kidney biopsy, kidney blood flow, kidney metabolism, kidney pancreas transplantation, lifestyle modification, medical history, molecular pathology, nonhuman, oxidative stress, risk factor, risk reduction, screening test, tea, treatment planning, aldose reductase inhibitor/dt [Drug Therapy], aldosterone antagonist/cb [Drug Combination], aldosterone antagonist/dt [Drug Therapy], aliskiren/dt [Drug Therapy], aminoguanidine/dt [Drug Therapy], angiotensin receptor antagonist/cb [Drug Combination], angiotensin receptor antagonist/dt [Drug Therapy], atrasentan/dt [Drug Therapy], avosentan/dt [Drug Therapy], bardoxolone/dt [Drug Therapy], neutrophil gelatinase associated lipocalin/ec [Endogenous Compound], palosuran/dt [Drug Therapy], phosphodiesterase inhibitor/dt [Drug Therapy], pirfenidone/dt [Drug Therapy], pyridoxamine/dt [Drug Therapy], renin inhibitor/cb [Drug Combination], renin inhibitor/dt [Drug Therapy], sulodexide/dt [Drug Therapy], transforming growth factor beta1/ec [Endogenous Compound], unclassified drug, unindexed drug, vitamin D/dt [Drug Therapy], zinc, protein L FABP/ec [Endogenous Compound], vasculotropin/ec [Endogenous Compound], biological marker/ec [Endogenous Compound], calcium channel blocking agent/cb [Drug Combination], calcium channel blocking agent/dt [Drug Therapy], connective tissue growth factor/ec [Endogenous Compound], cystatin C/ec [Endogenous Compound], cytokine/ec [Endogenous Compound], dipeptidyl carboxypeptidase inhibitor/cb [Drug Combination], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], fish oil, hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], kidney injury molecule 1/ec [Endogenous Compound], alternative medicine, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41642Test
International Journal of Nephrology and Renovascular Disease
Click here for full text options
LibKey Link

مصطلحات الفهرس: diabetic nephropathy/di [Diagnosis], diabetic nephropathy/dt [Drug Therapy], diabetic nephropathy/ep [Epidemiology], diabetic nephropathy/et [Etiology], diabetic nephropathy/su [Surgery], diabetic nephropathy/th [Therapy], diet therapy, disease surveillance, drug effect, drug targeting, glycemic control, human, inflammation, intracellular signaling, kidney biopsy, kidney blood flow, kidney metabolism, kidney pancreas transplantation, lifestyle modification, medical history, molecular pathology, nonhuman, oxidative stress, risk factor, risk reduction, screening test, tea, treatment planning, aldose reductase inhibitor/dt [Drug Therapy], aldosterone antagonist/cb [Drug Combination], aldosterone antagonist/dt [Drug Therapy], aliskiren/dt [Drug Therapy], aminoguanidine/dt [Drug Therapy], angiotensin receptor antagonist/cb [Drug Combination], angiotensin receptor antagonist/dt [Drug Therapy], atrasentan/dt [Drug Therapy], avosentan/dt [Drug Therapy], bardoxolone/dt [Drug Therapy], neutrophil gelatinase associated lipocalin/ec [Endogenous Compound], palosuran/dt [Drug Therapy], phosphodiesterase inhibitor/dt [Drug Therapy], pirfenidone/dt [Drug Therapy], pyridoxamine/dt [Drug Therapy], renin inhibitor/cb [Drug Combination], renin inhibitor/dt [Drug Therapy], sulodexide/dt [Drug Therapy], transforming growth factor beta1/ec [Endogenous Compound], unclassified drug, unindexed drug, vitamin D/dt [Drug Therapy], zinc, protein L FABP/ec [Endogenous Compound], vasculotropin/ec [Endogenous Compound], biological marker/ec [Endogenous Compound], calcium channel blocking agent/cb [Drug Combination], calcium channel blocking agent/dt [Drug Therapy], connective tissue growth factor/ec [Endogenous Compound], cystatin C/ec [Endogenous Compound], cytokine/ec [Endogenous Compound], dipeptidyl carboxypeptidase inhibitor/cb [Drug Combination], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], fish oil, hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], kidney injury molecule 1/ec [Endogenous Compound], alternative medicine, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41642Test
International Journal of Nephrology and Renovascular Disease
Click here for full text options
LibKey Link